Please login to the form below

Not currently logged in
Email:
Password:

data access

This page shows the latest data access news and features for those working in and with pharma, biotech and healthcare.

ABPI blames doctor payment disclosure dip on GDPR

ABPI blames doctor payment disclosure dip on GDPR

on 26 May 2018 and is designed to introduce a common set of standards for handling personal data. ... The ABPI provides data in an alphabetised Excel table, while in some other countries data are only available as separate PDFs from companies, making the

Latest news

  • UK pharma cheers EU science announcement UK pharma cheers EU science announcement

    a greater emphasis on ‘open science’predicated on free access to publications and data. ... Earlier this week the EU’s budget commissioner Günther Oettinger suggested at a conference in Brussels that access could be dependent on allowing freedom

  • Health insurers will test blockchain for data handling Health insurers will test blockchain for data handling

    Health insurers will test blockchain for data handling. Aims to make health records more accurate and reliable. ... The net benefit should be improved data accuracy, streamlined administration and improved access to care, they suggest.

  • Cello Health launches new social media and analytics offering Cello Health launches new social media and analytics offering

    More specifically, the new business venture will provide clients access to data sources, including the online conversations and validated views of healthcare professionals to complement the data generated from the vast ... more so, an appetite to be able

  • Duchenne UK and pharma partner pilot data-sharing HTA approach Duchenne UK and pharma partner pilot data-sharing HTA approach

    Duchenne UK and pharma partner pilot data-sharing HTA approach. Pfizer, Roche and PTC Therapeutics are among those participating in Project Hercules. ... These delays are worsened for diseases as there is often limited evidence available to meet the

  • Roche acquires US laboratory big data company Viewics Roche acquires US laboratory big data company Viewics

    Roche has bought a US software firm to gain access to its cloud-based big data platform for laboratory IT systems. ... The firm’s CEO Keith Laughman said its mission was to “provide unprecedented access to disparate healthcare data to surface

More from news
Approximately 3 fully matching, plus 201 partially matching documents found.

Latest Intelligence

  • The rise of vertical integration in the US payer landscape The rise of vertical integration in the US payer landscape

    Finally, IngenioRx will benefit from access to larger data sets, including medical claims, allowing more advanced analyses and decision-making. ... The combined medical/pharmacy data sets mean a possibility of more options in value-based contracting.

  • 30 Women Leaders in UK Healthcare

    Joanne Hackett and the Genomics England team are still developing business models for external access to the data, but if they can find the right formula for this (while safeguarding data ... Backed by IQVIA’s powerhouse of data and analytics, Angela

  • Protecting patient privacy Protecting patient privacy

    Accurate risk measurement. Support for process automation. Indeed, EMA is encouraging companies to move away from document redaction towards other data anonymisation approaches. ... It is not in the spirit of clinical data transparency and it adds the

  • The true potential of mobile health tech The true potential of mobile health tech

    could lead to patient overload with pharma companies, HCPs and patient associations clamouring for access to their data, he fears. ... I think there’s a potential shift, or opportunity, in terms of how QoL data is collected, which is potentially really

  • Passing fad or game changer? Passing fad or game changer?

    2. Barrier: ‘We can’t capture the data to measure outcomes robustly.’Approach:. ... Regulators and providers are increasingly driving policy change to allow key stakeholders to get access to data for the benefit of all.

More from intelligence
Approximately 0 fully matching, plus 51 partially matching documents found.

Latest appointments

  • Medmeme appoints Dr Joseph Laudano to medical affairs role Medmeme appoints Dr Joseph Laudano to medical affairs role

    He said: “The medical affairs function is in the process of evolving from a traditional support role into a more robust, strategic organisation for data generation and dissemination. ... Mahesh Naithani, founder of Medmeme, said: “Medmeme has been

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    I look forward to building on the compelling clinical data and initial market access work the PLx management team has begun and to successfully launching PL2200 Aspirin into the U.S.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Is the pharma business model ready for precision medicine?

    It exists at the convergence of genomic sequencing, biomarker research, bioinformatics and big data analysis. ... They will also need access to larger and more complex data sets and to develop the analytical capability to analyse them.

  • How will new data protection law affect pharma?

    The next step is to define the legal basis for processing data e.g. ... Pharma must also be prepared to respond in the event of an access request or complaint from a data subject, or with regards to a GDPR breach.

  • Market Access Transformation

    Market Access Transformation. MAT offers an online, information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and feedback from the largest and most diverse ... Director And Head Of

  • Cello Health appoints health economics and market access expert in the United States

    Han specializes in health economics, market access strategy, and data mining. ... Julia Ralston, CEO of Cello Health, US, commented, “ Yi brings us the perfect blend of technical and commercial expertise in HEOR data generation and also market access

  • The Heart of the Matter 7: Reality Dawns

    type. The FDA recently showcased this work as an example of how they welcome non-interventional data to supplement filings and accelerate approvals and access.". ... Careful consideration needs to be given to the research question, the quality of the

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics